PER 3.49% 8.3¢ percheron therapeutics limited

Ann: ATL1103/atesidorsen Early Access Program - Update, page-2

  1. 35,692 Posts.
    lightbulb Created with Sketch. 552
    lol same as with 1102 EA 3 years ago and them highlighting the price of current approved treatments like it's some kind of ball park figure. Again I bet they wont be selling an experimental drug with EA anywhere near the price of approved treatments. We'll see I guess.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.